Dr. Adler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7310 Ritchie Highway
512
Glen Burnie, MD 21061Phone+1 410-761-7042Fax+1 410-761-7984
Summary
- I am board-certified in psychiatry and geriatric psychiatry. I am owner and director of Clinical Insights, Inc., an independent clinical research center.
Education & Training
- Sheppard and Enoch Pratt HospitalResidency, Psychiatry, 1976 - 1979
- University of Maryland School of MedicineClass of 1976
- University of Maryland, College ParkB.S., Biochemistry, Cum Laude, 1971
Certifications & Licensure
- MD State Medical License 1976 - 2026
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
- American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Noxell Merit Scholarship, Outstanding Undergraduate Chemistry Major University of Maryland, 1969
Clinical Trials
- Treatment-Resistant Depression Registry Start of enrollment: 2006 Jan 01
- Escitalopram for Agitation in Alzheimer's Disease Start of enrollment: 2018 Jan 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 78 citationsDiagnostic criteria for apathy in neurocognitive disordersDavid Miller, Philippe Robert, Larry Ereshefsky, Lawrence Adler, Daniel R. Bateman
Alzheimer's & Dementia. 2021-05-05 - Valproate-Induced Hyperammonemic Encephalopathy in a General Hospital.William T. Regenold, Lawrence Adler
Psychosomatics. 2018-01-01 - 10 citationsElevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor AntihypertensivesWilliam T. Regenold, Jacob B. Blumenthal, David Loreck, Kristen L Mordecai, Gina Scarinzi
American Journal of Alzheimer's Disease and Other Dementias. 2017-04-27
Journal Articles
- Valproate-related Hyperammonemia in Older Adult Psychiatric InpatientsAdler LW, Regenold WT, The Primary Companion to CNS Disorders, 1/1/2014
- Lisinopril May Augment Antidepressant ResponseHertzman M, Adler LW, Arlen B, Kern M, Journal of Clinical Psychopharmacology, 1/1/2005
- Improving Clinical Trials: American Society of Clinical Psychopharmacology RecommendationsKlein DF, Thase ME, Endicott J, Adler L., Glick I., Kalali A., Leventer S., Mattes J., Ross P., Bystristsky A, University of Maryland School of Medicine, 3/1/2002
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Catatonia Model as Dysregulated Glutamatergic Cortico-thalamo-cortico NeurotransmissionAdler L, Regenold WT, Doddi S, CINP (International College of Neuropsychopharmacology) World Congress, Vancouver, Canada, 6/1/2014
- Valproate-Related Hyperammonemia in Older Psychiatric InpatientsAdler L, Regenold WT, Lachner C, Martin C, John D, Nakkalupu S, American Association of Geriatric Psychiatry, Orlando, FL, 1/1/2014
- Remission of Major Depressive Episodes on Paroxetine vs. Placebo in Elderly and Adult SubjectsAdler LW, American Association of Geriatric Psychiatry Annual Meeting, New Orleans, LA, 1/1/2007
- Join now to see all
Lectures
- An In-Depth View of What Drives Investigators DecisionsWashington, D.C. - 1/1/2010
- Neuroleptic Dosages of First-Episode Schizophrenic Patients in Maryland Public HospitalsMontego Bay, Jamaica - 2/1/1996
- Treatment of Psychosis in Elderly Patients with Seroquel (ICI 204,636)Montego Bay, Jamaica - 2/1/1996
- Join now to see all
Other
- Re: Benzodiazepine Use and Risk of Alzheimer's Disease: Case-control StudyAdler LW
http://www.bmj.com.proxy-hs.researchport.umd.edu/content/349/bmj.g5205/rr/779123
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: